Assessing the Impact of a Safe and Equitable Biosimilar Policy in the United States
Assessing the Impact of a Safe and Equitable Biosimilar Policy in the United States
United States United States Congress, Committee on Energy and Commerce, United States House of Representatives
Details
- OL Work ID
- OL30241084W